Squarepoint’s Nexalin Technology NXL Stock Holding History

Squarepoint’s Portfolio NXL Stock Details NXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-12,631	Closed	-$21.3K	–	4523
2024 Q2	$21.3K	Buy	+12,631	New	+$18.6K	﹤0.01%	3959

Other funds holding NXL

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

AWS

Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

Squarepoint's NXL Position: Q3 2024 in Review

Squarepoint sold out of Nexalin Technology (NXL) in Q3 2024, closing a stake of 12,631 shares — an estimated $21.3K sold.

Squarepoint first reported a position in NXL in Q2 2024 and held it in 1 quarter. The position peaked at $21.3K in Q2 2024. 15 funds tracked by Wall St. Rank hold NXL as of Q3 2024.

Squarepoint reported no remaining Nexalin Technology position as of Q3 2024 after selling out during the quarter.
Squarepoint sold 12,631 Nexalin Technology shares in Q3 2024, an estimated $21.3K.
Squarepoint first reported a position in Nexalin Technology in Q2 2024 and held it in 1 quarter.
Squarepoint's Nexalin Technology position peaked at $21.3K in Q2 2024.
15 funds tracked by Wall St. Rank held Nexalin Technology as of Q3 2024.

Based on Squarepoint's 13F filing for Q3 2024, filed 14 Nov 2024.